(30 days)
Not Found
No
The summary describes a standard ultrasound system with basic imaging and measurement capabilities, and there is no mention of AI or ML in the device description, intended use, or specific sections for AI/ML details.
No
The device is described as a diagnostic ultrasound system used for imaging and measurement, not for treatment.
Yes
The device description explicitly states, "The SIUI CTS-5500/CTS-6600 is a portable diagnostic ultrasound system."
No
The device description explicitly states it consists of probes, a main unit, a control panel, and a monitor, which are all hardware components.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD devices are used to examine specimens obtained from the human body (like blood, urine, tissue) to provide information for diagnosis, monitoring, or screening.
- This device is an ultrasound system. Ultrasound uses sound waves to create images of internal organs and structures within the body. It does not analyze samples taken from the body.
The intended use and device description clearly indicate it's an imaging device for visualizing internal anatomy, not for testing biological samples.
N/A
Intended Use / Indications for Use
Ultrasonic pulsed echo imaging and measurement for abdominal, pediatric, small organ, cardiac, peripheral vascular applications
Product codes (comma separated list FDA assigned to the subject device)
IYN, IYO, ITX
Device Description
The SIUI CTS-5500/CTS-6600 is a portable diagnostic ultrasound system capable of the following operating modes: 2D (B mode), M and B/M. The system is designed for use in linear and convex scanning modes and supports linear and convex transducers. The system has cine review, image zoom, measurements and calculations, printing and recording capabilities. The system consists of probes, main unit, control panel and monitor.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Ultrasonic pulsed echo imaging
Anatomical Site
Abdominal, pediatric, small organ, cardiac, peripheral vascular, fetal, thyroid, parathyroid, parotid, submaxillary gland, testes, breast
Indicated Patient Age Range
Pediatric, Adult
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.1550 Ultrasonic pulsed doppler imaging system.
(a)
Identification. An ultrasonic pulsed doppler imaging system is a device that combines the features of continuous wave doppler-effect technology with pulsed-echo effect technology and is intended to determine stationary body tissue characteristics, such as depth or location of tissue interfaces or dynamic tissue characteristics such as velocity of blood or tissue motion. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II.
0
JUN 3 0 2006
SIUI CTS-5500/6600 Ultrasound Imaging System
Section 7 Summary of Safety and Effectiveness
Trade Name: | CTS-5500/CTS-6600 with C3I40 and L7I50 Transducers |
---|---|
Common Name: | Diagnostic Ultrasound System |
Classification Name: | Ultrasonic Pulsed Echo Imaging System, 90 IYO |
(Per 21 CFR section 892.1560) | |
Manufacturer's Name: | Shantou Institute of Ultrasonic Instruments |
Address: | #77, Jinsha Road, |
Shantou SEZ, 515041, China | |
Corresponding Official: | Li Delai |
Title: | President |
Telephone: | (86) 754-8250150 Fax: (86) 754-8251499 |
US Agent: | Bob Leiker/ Consultant /QRS |
Dublin, CA 94568 | |
Telephone: 1-925-556-1302 Fax: 1-866-718-3819 |
SIUI CTS-485 , K012772 Predicate Device:
Device Description: The SIUI CTS-5500/CTS-6600 is a portable diagnostic ultrasound system capable of the following operating modes: 2D (B mode), M and B/M. The system is designed for use in linear and convex scanning modes and supports linear and convex transducers. The system has cine review, image zoom, measurements and calculations, printing and recording capabilities. The system consists of probes, main unit, control panel and monitor.
Intended Use: Ultrasonic pulsed echo imaging and measurement for abdominal, pediatric, small organ, cardiac, peripheral vascular applications
Technological Characteristics:
-
Scanning modes: convex and linear scanning
-
Display modes: a) B-Mode (B, 2B) b) M-Mode c) B/M-Mode
-
Grey scale: 256
-
Frequency of probe: 2.5MHz to 9.0MHz
Section 7
Summary of Safety and Effectiveness
Page 1 of 2
1
SIUI CTS-5500/6600 Ultrasound Imaging System
-
- Image Display multiple: x1.0, x1.5, x2.0; Shift 2mm step
-
- Focusing method: Variable aperture 1-4 focal zone electronic focusing
-
- Display range (max):
Depth 210mm angle 82°(Convex probe)
Depth 140mm width 50mm (Linear probe)
-
- Image adjustment:
- a) Gain: 0 to 99 (digital) c) Grey map curve: 8 b) TGC: 6 steps
types
- d) Frame correlation: 4 steps e) Edge enhance: 4 steps
-
- M-mode speed:
Time for full screen scroll: 1, 2, 4, 8 sec
-
- Cineloop: 64 frames.continual/single
-
- DSC memory capacity: 512x512x8 bit
-
- Image display: Left/right, positive/negative
-
- Monitor: 10-inch B/W monitor
-
- Character display
- a) Patient's ID b) Hospital Name c) Comment
d) Automatically display items: Date & time, probe frequency, gain and other operating parameters
-
- Body marks: 25 types
-
- Measurements and calculations
- (a) General measurements and calculations
2D: Distance, Area, Circumference, and Angle
M-Mode: Distance, Time, Slope, Heart rate
- (b) Obstetrics measurements: BPD, CRL, FL, AC, HC, GS, VOL, ANG
- (c) Other measurements
-
- I/O port
RS-232C port for transmitting images to PC
-
- Dimension: 320(w) x415 (I) x310 (h) mm
-
- Net Weight: approx. 11kg for CTS-5500, 10kg for CTS-6600
-
- Power Consumption:
220V±10, 110VA or 110V±10, 110VA
2
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JUN 3 0 2006
Shantou Institute of Ultrasonic Instruments (SIUI) % Mr. Bob Leiker Quality & Regulatory Services 7263 Cronin Circle DUBLIN CA 94568
Re: K061488
Trade Name: CTS-5500/CTS-6600 Diagnostic Ultrasound Imaging System Regulation Number: 21 CFR 892.1550 Regulation Name: Ultrasonic pulsed doppler imaging system Regulatory Number: 21 CFR 892.1560 Regulatory Name: Ultrasonic pulsed echo imaging Regulation Number: 21 CFR 892.1570 Regulation Name: Diagnostic Ultrasonic transducer Regulatory Class: II Product Code: IYN, IYO, and ITX Dated: May 26, 2006 Received: May 31, 2006
Dear Mr. Leiker:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
This determination of substantial equivalence applies to the following transducers intended for use with the CTS-5500/CTS-6600 Diagnostic Ultrasound Imaging System, as described in your premarket notification:
Image /page/2/Picture/11 description: The image is a circular seal with the letters "FDA" in the center. The text "The New FDA Centennial" is arranged around the top and bottom of the circle. The seal is surrounded by a dotted border.
: Protecting and Promoting Public Health
3
Transducer Model Number
Convex Array C3140 Linear Array L7150
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This determination of substantial equivalence is granted on the condition that prior to shipping the first device, you submit a postclearance special report. This report should contain complete information, including acoustic output measurements based on production line devices, requested in Appendix G, (enclosed) of the Center's September 30, 1997 "Information for Manufacturers Seeking Marketing Clearance of Diagnostic Ultrasound Systems and Transducers." If the special report is incomplete or contains unacceptable values (e.g., acoustic output greater than approved levels), then the 510(k) clearance may not apply to the production units which as a result may be considered adulterated or misbranded.
The special report should reference the manufacturer's 510(k) number. It should be clearly and prominently marked "ADD-TO-FILE" and should be submitted in duplicate to:
Food and Drug Administration Center for Devices and Radiological Health Document Mail Center (HFZ-401) 9200 Corporate Boulevard Rockville, Maryland 20850
This letter will allow you to begin marketing your device as described in your premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus permits your device to proceed to market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small
![Image of a blurred text block]
4
Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/odrh/industry/support/index.html
If you have any questions regarding the content of this letter, please contact Andrew Kang, M.D. at (301) 594-1212.
Sincerely yours,
Nancy C. Brogdon
Director, Division of Reproductive, Abdominal and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure(s)
5
Diagnostic Ultrasound Indications for Use Form
1. System Indications for Use Form |
---|
------------------------------------ |
Device Name: CTS-5500/CTS-6600
Mode of Operation | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Clinical Application | A | B | M | PWD | CWD | Color Doppler | Power (Amplitude) Doppler | Color Velocity Imaging | Combined (Specify) | Other (Specify) |
Opthalmic | ||||||||||
Fetal | P | P | P | |||||||
Abdominal | P | P | P | |||||||
IntraOperative (Cardiac) | ||||||||||
IntraOperative Neurological | ||||||||||
Pediatric | P | P | P | |||||||
Small Organ (Specify) | P | P | P | |||||||
Neonatal Cephalic | ||||||||||
Adult Cephalic | ||||||||||
Cardiac | P | P | P | |||||||
Transesophageal | ||||||||||
Trans-Rectal | ||||||||||
Trans-Vaginal | ||||||||||
Trans-Urethral | ||||||||||
Intra-Vascular | ||||||||||
Peripheral Vascular | P | P | P | |||||||
Laparascopic | ||||||||||
Muscular-Skeletal Conventional | ||||||||||
Muscular-Skeletal Superficial | ||||||||||
Others (Specify) |
N = new indication P = previously cleared by FDA E = added under Appendix E
Additional Comments: Small organs includes: thyroid, parathyroid, parotid, submaxillary gland, testes and breast
Combined: B/M Mode
Pediatric Comments: Pediatric Intended Uses include: Cardiology, Abdomen, Peripheral Vascular
Pediatic Comments: Pediatic Intended Uses include: Cardiology, Abdomen, Peripheral Vascular
PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use (Per 21 CFR 801.109)
(Division Sign-Offi
Division of Reprod
and Radiological Devi
510(k) Number__
Section 8
Indications For Use
6
SIUI CTS-5500/6600 Ultrasound Imaging System
Diagnostic Ultrasound Indications for Use Form
Mode of Op
2. Transducer Indications for Use Form |
---|
---------------------------------------- |
Device Name: | Convex Array C3I40 |
---|---|
-------------- | -------------------- |
| Clinical Application | A | B | M | PWD | CWD | Color
Doppler | Power
(Amplitude)
Doppler | Color
Velocity
Imaging | Combined
(Specify) | Other
(Specify) |
|-----------------------------------|---|---|---|-----|-----|------------------|---------------------------------|------------------------------|-----------------------|--------------------|
| Opthalmic | | | | | | | | | | |
| Fetal | | P | P | | | | | | P | |
| Abdominal | | P | P | | | | | | P | |
| IntraOperative
(Cardiac) | | | | | | | | | | |
| IntraOperative
Neurological | | | | | | | | | | |
| Pediatric(Specify) | | P | P | | | | | | P | |
| Small Organ
(Specify) | | | | | | | | | | |
| Neonatal Cephalic | | | | | | | | | | |
| Adult Cephalic | | | | | | | | | | |
| Cardiac | | P | P | | | | | | P | |
| Transesophageal | | | | | | | | | | |
| Trans-Rectal | | | | | | | | | | |
| Trans-Vaginal | | | | | | | | | | |
| Trans-Urethral | | | | | | | | | | |
| Intra-Vascular | | | | | | | | | | |
| Peripheral Vascular | | | | | | | | | | |
| Laparascopic | | | | | | | | | | |
| Muscular-Skeletal
Conventional | | | | | | | | | | |
| Muscular-Skeletal
Superficial | | | | | | | | | | |
| Others (Specify) | | | | | | | | | | |
N = new indication P = previously cleared by FDA E = added under Appendix E
Additional Comments: Pediatric Comments: Pediatric Intended Uses include: Cardiology AbdomenAdditional Comments: Pediatric Comments: Pediatric Intended Uses include: Cardiology, Abdomen
Combined: B/M Mode
PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED
Concurrence of CDRH, office of Device Evaluation (ODE)
J. Horace Borden
(Division Sign-Off) Division of Reproductive, Abdom and Radiological Devices 510(k) Number
Prescription Use (Per 21 CFR 801.109)
Section 8
Indications For Use
7
Diagnostic Ultrasound Indications for Use Form
Device Name: Linear Array L7150
KOBIG
Mode of Operation
Clinical Application | A | B | M | PWD | CWD | Color | Power | Color | Combined | Other |
---|---|---|---|---|---|---|---|---|---|---|
Doppler | (Amplitude) | Velocity | (Specify) | (Specify) | ||||||
Doppler | Imaging | |||||||||
Opthalmic | ||||||||||
Fetal | ||||||||||
Abdominal | ||||||||||
IntraOperative | ||||||||||
(Cardiac) | ||||||||||
IntraOperative | ||||||||||
Neurological | ||||||||||
Pediatric | P | P | P | |||||||
Small Organ | P | P | P | |||||||
(Specify) | ||||||||||
Neonatal Cephalic | ||||||||||
Adult Cephalic | ||||||||||
Cardiac | ||||||||||
Transesophageal | ||||||||||
Trans-Rectal | ||||||||||
Trans-Vaginal | ||||||||||
Trans-Urethral | ||||||||||
Intra-Vascular | ||||||||||
Peripheral Vascular | P | P | P | |||||||
Laparascopic | ||||||||||
Muscular-Skeletal | ||||||||||
Conventional | ||||||||||
Muscular-Skeletal | ||||||||||
Superficial | ||||||||||
Others (Specify) |
P = previously cleared by FDA E = added under Appendix E N = new indication
Additional Comments: Small organs includes: thyroid, parotid, submaxillary gland, testes and breast
Combined: B/M Mode
Pediatric Comments: Pediatric Intended Uses include: Peripheral Vascular
PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED
Concurrence of CDRH, office of Device Evaluation (ODE)
Lila Carter
Division Sign-Off Presion of Reproductive, Abdominal. na Qadiologic
Prescription Use (Per 21 CFR 801.109)
-- •
Section 8
Indications For US